Purple Innovation, Inc.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
PRPL$1.80-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Deficit
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
(unaudited – in thousands)
| Class A · Class B · Additional · Total Stockholders’ Deficit attributable to Purple | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common Stock · Common Stock · Paid-in · Accumulated · Innovation, · Noncontrolling · Total | |||||||||
| Shares | Par Value | Shares | Par Value | Capital | Deficit | Inc. | Interest | Deficit | |
| Balance – December 31, 2025 | 4,330 | $— | 7 | $— | $595,593 | $(625,280) | $(29,687) | $18 | $(29,669) |
| Net loss | — | — | — | — | — | (30,541) | (30,541) | (35) | (30,576) |
| Stock-based compensation | — | — | — | — | 156 | — | 156 | — | 156 |
| Issuance of stock under equity compensation plans | 16 | — | — | — | (51) | — | (51) | — | (51) |
| Balance – March 31, 2026 | 4,346 | $— | 7 | $— | $595,698 | $(655,821) | $(60,123) | $(17) | $(60,140) |
| Net loss | — | — | — | — | — | (3,230) | (3,230) | (16) | (3,246) |
| Stock-based compensation | — | — | — | — | (377) | — | (377) | — | (377) |
| Issuance of stock under equity compensation plans | 7 | — | — | — | (37) | — | (37) | — | (37) |
| Balance – June 30, 2026 | 4,353 | — | 7 | — | 595,284 | $(659,051) | $(63,767) | $(33) | $(63,800) |
| Net loss | — | — | — | — | — | (1,398) | (1,398) | (22) | (1,420) |
| Stock-based compensation | — | — | — | — | 49 | — | 49 | — | 49 |
| Exchange of stock | 4 | — | (4) | — | — | — | — | — | — |
| Impact of transactions affecting NCI | — | — | — | — | (32) | — | (32) | 32 | — |
| Balance – September 30, 2026 | 4,357 | $— | 3 | — | $595,301 | $(660,449) | $(65,148) | $(23) | $(65,171) |
| Class A · Class B · Additional · Total Stockholders’ Equity (Deficit) attributable to Purple · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common Stock · Common Stock · Paid-in · Accumulated · Innovation, · Noncontrolling · Equity | |||||||||
| Shares | Par Value | Shares | Par Value | Capital | Deficit | Inc. | Interest | (Deficit) | |
| Balance – December 31, 2024 | 107,545 | $11 | 165 | $— | $594,053 | $(573,866) | $20,198 | $11 | $20,209 |
| Net loss | — | — | — | — | — | (19,137) | (19,137) | (29) | (19,166) |
| Stock-based compensation | — | — | — | — | 368 | — | 368 | — | 368 |
| Issuance of stock under equity compensation plans | 410 | — | — | — | (81) | — | (81) | — | (81) |
| Impact of transactions affecting NCI | — | — | — | — | (8) | — | (8) | 8 | — |
| Balance – March 31, 2025 | 107,955 | $11 | 165 | $— | $594,332 | $(593,003) | $1,340 | $(10) | $1,330 |
| Net loss | — | — | — | — | — | (17,345) | (17,345) | (26) | (17,371) |
| Stock-based compensation | — | — | — | — | 477 | — | 477 | — | 477 |
| Issuance of stock under equity compensation plans | 289 | — | — | — | (100) | — | (100) | — | (100) |
| Accrued Distribution True-up | — | — | — | — | 85 | — | 85 | — | 85 |
| Impact of transactions affecting NCI | — | — | — | — | (96) | — | (96) | 96 | — |
| Balance – June 30, 2025 | 108,244 | $11 | 165 | $— | $594,698 | $(610,348) | $(15,639) | $60 | $(15,579) |
| Net loss | — | — | — | — | — | (11,720) | (11,720) | (28) | (11,748) |
| Stock-based compensation | — | — | — | — | 420 | — | 420 | — | 420 |
| Exchange of stock | 2 | — | (2) | — | — | — | — | — | — |
| Balance – September 30, 2025 | 108,246 | $11 | 163 | $— | $595,118 | $(622,068) | $(26,939) | $32 | $(26,907) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.